comparemela.com

Latest Breaking News On - Hypersomnia foundation - Page 5 : comparemela.com

Harmony Biosciences Announces 2022 Funding Recipients of Patients at the Heart And Progress at the Heart Award Programs

Harmony Biosciences Holdings Inc revealed the funding recipients of its Patients at the Heart and Progress at the Heart award programs.

New yorkUnited statesColumbia universityWashington heightsWorld sleep societyInternational sleep medicine examinationWorld sleep society medicine examinationDivision of cardiologyPublic healthPrader willi syndrome association united statesDiverse population of high school studentsDiversity leadership programMuscular dystrophy associationInteractive forum for relational connectionsHypersomnia foundationCommunity programs

HARMONY BIOSCIENCES ANNOUNCES 2022 FUNDING RECIPIENTS OF PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD PROGRAMS

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony") (NASDAQ: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative.

New yorkUnited statesColumbia universityWashington heightsNancy leoneLuis sanayCorporate affairs officerWorld sleep societyInternational sleep medicine examinationWorld sleep society medicine examinationPrnewswire harmony biosciences holdings incDivision of cardiologyPublic healthPrader willi syndrome association united statesDiverse population of high school studentsDiversity leadership program

Hypersomnia Foundation Appoints New CEO, COO

The Hypersomnia Foundation recently announced the appointment of two new leaders within their organization.

David burleyLindsay jesteadtWorld sleep societyHypersomnia foundationClaire crispWaking mathildaSleep consortiumWorld sleep

How to Manage Psychosocial Challenges of Pediatric Narcolepsy

The psychosocial effects of pediatric narcolepsy can have far-reaching consequences that are sometimes overlooked by sleep specialists.

United statesDavid ingramShalini paruthiJose colonRisa kerslakeKevin smithHypersomnia foundationResearch center at stSleep medicineResearch centerMercy kansas cityMercy kansasClinical sleepWake up narcolepsyClin sleep

NLS Pharmaceutics Announces Positive Opinion from European Regulators to Grant Orphan Drug Designation for Mazindol ER in Idiopathic Hypersomnia

NLS Pharmaceutics Announces Positive Opinion from European Regulators to Grant Orphan Drug Designation for Mazindol ER in Idiopathic Hypersomnia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAlex zwyerCindy rizzoPascal nigenHypersomnia foundationEuropean commissionPharmaceutics ltdExchange commissionAlpha bronzeEuropean unionEuropean medicines agencyHealth technology assessmentsCommittee for orphan medical productsOrphan medical productsOrphan drug designationChief executive officer

vimarsana © 2020. All Rights Reserved.